(WKBW/ABC News) The makers of the world's best selling cancer drug appeared at a Food and Drug administration meeting, asking the agency to reconsider its decision to stop using Avastin for breast cancer treatment.
The drug was approved in 2008 to treat advanced stage breast cancer that has spread to other parts of the body and is considered incurable.
Last July, the FDA voted to revoke the drug as a breast cancer treatment over concerns about its effectiveness and side effects, like holes in the stomach and intestines, severe bleeding and blood clots.
The FDA says Avastin neither extends nor improves life for breast cancer patients, but it can still be used to treat other cancers.
If the FDA pulls the plug on Avastin, doctors could still prescribe it, but
insurance won't likely cover it, and one year's treatment can run more than 100-thousand dollars.
A response from the FDA is expected to take at least several weeks.